Home > Sports > News > Reuters > Report

Boulami banned for two years

November 20, 2003 11:09 IST

Morocco's steeplechase world record holder Brahim Boulami has been banned for two years after testing positive for erythropoietin (EPO), the Court of Arbitration for Sport (CAS) said on Wednesday.

Boulami, 31, smashed his own world record for the 3,000 metres steeplechase of seven minutes 55.28 seconds set in Brussels in 2001 when he clocked an astonishing 7:53.17 on August 16 in Zurich last year.

Brahim BoulamiBut blood and urine tests taken the previous day showed traces of the banned stamina-boosting substance EPO in the athlete's body. EPO boosts oxygen-carrying red cells in the blood.

The Zurich world record is awaiting ratification, according to the International Association of Athletics Federations (IAAF) website.

The Moroccan Athletics Federation decided in February not to sanction Boulami because of doubts over the testing methods, CAS said on Wednesday in a statement.

Also Read


Boulami breaks own world record to steal show

Boulami awaits fate after positive dope test


The IAAF, however, filed an appeal with CAS on April 11 2003 to ask that the athlete receive a two-year ban in accordance with the world governing body's anti-doping rules.

A three-man CAS panel sat for two days in October to hear the case.

"The tribunal has come to the conclusion that the prohibited substance EPO was present in Brahim Boulami's urine," the Lausanne-based CAS said in a statement on Wednesday.

"It has also found that the urine test performed by the laboratory in charge of the analyses was reliable and valid."

CAS said Boulami's two-year ban would be backdated to start from August 28 2002.


Article Tools

Email this Article

Printer-Friendly Format

Letter to the Editor




Related Stories


Doping: Athletics sinks deeper

Paris samples to be re-tested

'I tested positive for steroid'



People Who Read This Also Read


Boulami's positive dope test

Schumi primed for seventh title

Shared W'Cup in Africa possible






© Copyright 2003 Reuters Limited. All rights reserved. Republication or redistribution of Reuters content, including by framing or similar means, is expressly prohibited without the prior written consent of Reuters. Reuters shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.










Copyright © 2003 rediff.com India Limited. All Rights Reserved.